Research Communication: Effects of Screening Colonoscopy on Colorectal Cancer Mortality: Lessons From Comparative...

Area of Science:

• Gastroenterology
• Preventive Medicine
• Clinical Trials

Background:

• The NordICC trial, a randomized study on screening colonoscopy, did not show a significant reduction in colorectal cancer (CRC) mortality.
• Comparing NordICC with the NORCCAP sigmoidoscopy trial provides insights into screening effectiveness.

Purpose of the Study:

• To analyze whether the NordICC trial's follow-up duration adequately captured the long-term effects of screening colonoscopy on CRC mortality.
• To compare CRC mortality trends between the NordICC and NORCCAP trials.

Main Methods:

• Comparative analysis of 10-year CRC mortality data from the NordICC (colonoscopy) and NORCCAP (sigmoidoscopy) trials.
• Examination of CRC mortality trends in relation to follow-up duration in both trials and other sigmoidoscopy studies.

Main Results:

• The NordICC trial reported no significant decrease in CRC mortality at 10 years.
• In the NORCCAP trial, significant CRC mortality reductions became apparent after 9.5 years and increased substantially by 12 years.
• Other sigmoidoscopy trials also demonstrated benefits at 11-12 years of follow-up.

Conclusions:

• The apparent lack of benefit in the NordICC trial may be attributed to insufficient follow-up duration.
• Longer follow-up periods are crucial for accurately assessing the long-term impact of colorectal cancer screening interventions on mortality.